M. Biegstraaten

Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease

M. Biegstraaten, Timothy M. Cox, Nadia Belmatoug et al. · Blood Cells Molecules and Diseases · 2016 · 126 citations · Full text

Disease Management, Clinical Specialties, Substrate Reduction Therapy +19

A monozygotic twin pair with highly discordant Gaucher phenotypes

M. Biegstraaten, Ivo N. van Schaik, Johannes M. F. G. Aerts et al. · Blood Cells Molecules and Diseases · 2010 · 68 citations · Full text

Biology, Allelic Variant, Quantitative Genetics +5

Determining the optimal flexion–extension axis of the elbow in vivo — a study of interobserver and intraobserver reliability

M. Stokdijk, M. Biegstraaten, W Ormel et al. · Journal of Biomechanics · 2000 · 48 citations

Mechanobiology, Optimal Flexion–extension Axis, Kinesiology +9

Hearing loss in children with Fabry disease

Eefje B. Suntjens, Wouter A. Dreschler, Jeanette Hess-Erga et al. · Journal of Inherited Metabolic Disease · 2017 · 16 citations · Full text

Factors Contributing to the Efficacy-Effectiveness Gap in the Case of Orphan Drugs for Metabolic Diseases

Yvonne Schuller, Carla E. M. Hollak, Christine C. Gispen‐de Wied et al. · Drugs · 2017 · 11 citations · Full text